BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REMEDi4ALL
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20231114T090000
DTEND;TZID=Europe/Amsterdam:20231114T173000
DTSTAMP:20260421T204918
CREATED:20230915T105013Z
LAST-MODIFIED:20231016T150222Z
UID:3297-1699952400-1699983000@remedi4all.org
SUMMARY:REMEDi4ALL MULTI-STAKEHOLDER MEETING: Drug Repurposing\, an Attractive Strategy in Pancreatic Cancer Treatment?
DESCRIPTION:REMEDi4ALL is pleased to announce the first Multi-Stakeholder Meeting on drug repurposing in PANCREATIC CANCER. \nThis one-day in person workshop is aimed to bring together all relevant key stakeholders (patients and patient representatives\, academia\, industry\, regulators\, funders\, etc.) to discuss the recent state of art on drug repurposing in oncology and specifically in pancreatic cancer. Topics of discussion will include an overview of the disease and the current (preclinical and clinical) drug repurposing programs\, biomarkers\, the importance of a patient-centred outcome measures and patient engagement activities in the study design and implementation. In addition\, current hurdles including financial and regulatory barriers to successfully repurpose non-oncology drugs in pancreatic cancer will also be discussed. \nREGISTER HERE \nPreliminary Agenda (might be subject to change) \n\n\n\n8.30 – 9.00 \nWelcome and Registration \n\n\n9.00 – 9.10  \nOpen Ceremony  \nClaudia Fuchs  (REMEDi4ALL – EURORDIS) \n\n\n SESSION 1: SETTING THE SCENE  \nModerator: Claudia Fuchs (REMEDi4ALL – EURORDIS)  \n\n\n9.10 – 9.30  \nGeneral Introduction on Pancreatic Cancer \nAlfredo Carrato (Pancreatic Cancer Europe – PCE)  \n\n\n9.30 – 9.50 \nTackling pancreatic cancer: tricks and tips \nIlse Rooman (Anticancer Fund\, Vrije Universiteit Brussels) \n\n\n9.50 – 10.10  \nDrug repurposing in oncology – Attractive but not that simple \nGauthier Bouche  (REMEDi4ALL – Anticancer Fund) \n\n\n10.10– 10.25 \nREMEDi4ALL  (vision\, mission\, European Context) \nDonald Lo  (REMEDi4ALL – EATRIS) \n\n\n10.25 – 11.10 \nPatient Perspective on Drug Repurposing in Oncology \nPatrycja Rzadkowska (Pancreatic Cancer Europe – PCE and DiCE)   \nAli Stunt (Pancreatic Cancer Europe – PCE and Pancreatic Cancer Action UK)   \n\n\n COFFE BREAK 11.10 – 11.40 \n\n\n SESSION 2: TREATMENT OPTIONS AND DRUG REPURPOSING OPPORTUNITIES IN PANCREATIC CANCER   \nModerators: Gauthier Bouche/Patricia Vandamme (REMEDi4ALL – Anticancer Fund)  \n\n\n11.40 – 12.00 \nOrphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation \nVioleta Stoyanova-Beninska (Medicines Evaluation Board\, Chair of Committee for Orphan Medicinal Products at EMA) \n\n\n12.00 – 12.20  \nPreclinical and Clinical Updates on Drug Repurposing Opportunities in Pancreatic Cancer \nLuca Cardone  (Istituto Nazionale Tumori Regina Elena and National Research Council of Italy)  \n\n\n12.20– 12.40 \nPatient Story  \nSteve Bigelsen  (Rutgers New Jersey Medical School\, Newark\, NJ\, USA) \n\n\n12.40 – 13.00  \nThe VESPA Trial – Repurposing valproic acid combined with simvastatin to potentiate first line gemcitabine/nab-paclitxel-chemotherapy regimen in metastatic pancreatic cancer patients \nAlfredo Budillon (REMEDi4ALL – Istituto Nazionale Tumori Fondazione Pascale)  \n  \n  \n\n\n LUNCH BREAK 13.00 – 14.00  \n\n\n SESSION 3: THE PAST\, PRESENT AND FUTURE OF PANCREATIC CANCER CLINICAL TRIALS  \nModerators: Eve Hewitt/Rick Thompson (REMEDi4ALL- Beacon)  \n\n\n14.00 – 14.40 \nFinancial and Regulatory Barriers and Potential Solutions  \n– Overview on the current findings within REMEDi4ALL and future perspectives \n– Industry perspective  \n– Funders persepective \nHeleen van der Meer (REMEDi4ALL – ZonMW)  \nRaluca Radu  (REMEDi4ALL – Medicines for Europe)  \nHans Platteeuw  (CEO Galenicap)  \nAlexandre Bento Costa Alencar  (Rising Tide Foundation) \n\n\n14.40 – 15.00 \nBiomarkers in Pancreatic Cancer \nMaría Laura Garcia Bermejo  (Ramon & Cajal Health Research Institute) \n\n\n15.00 – 15.20 \nPatient Centricity in Clinical Trials  \nAntonella Cardone  (Cancer Patients Europe – CPE)  \nFederica Valsecchi  (Fondazione Valsecchi) \n\n\n COFFE BREAK 15.20 – 15.50   \n\n\n  \n15.50 – 17.20  \n FINAL ROUNDTABLE AND DISCUSSION  \nModerators: Claudia Fuchs (REMEDi4ALL – EURORDIS) – Rick Thompson (REMEDi4ALL – Beacon) \n\n\n17.20 – 17.30    \nClosing Remarks   \nClaudia Fuchs (REMEDi4ALL – EURORDIS)  \nRick Thompson (REMEDi4ALL – Beacon) \n\n\n17.30 \nEnd of the Meeting  and “GET TOGETHER”  \n 
URL:https://remedi4all.org/event/remedi4all-multi-stakeholder-meeting/
LOCATION:Nhow Brussels Bloom\, Rue Royale 250\, 1210\, Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2023/09/Banner-1st-MSM_v2.png
END:VEVENT
END:VCALENDAR